Please login to the form below
Inceptua
This page shows the latest Inceptua news and features for those working in and with pharma, biotech and healthcare.
Multipharma launches Inceptua Medicines Access
The group will be split into three sub-divisions. Multipharma has launched Inceptua Medicines Access, a speciality business unit that offers access to pre-approval and unlicensed medicines. ... All Inceptua three divisions will harness
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Transforming Access to Medicines Through Patient-Centric Solutions
To do this Inceptua Medicines Access and patient group, HAEi, in association with PMGroup, will host a free webinar on Thursday 14th December that will cover both the pre-approval access ... Mark Corbett, Executive Vice President at Inceptua Medicines
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Inceptua Medicines Access appoints senior new-hires
Multipharma’s new speciality business unit, Inceptua has appointed Ruth Rostron as its new senior project manager, a role that will see her focus on design and implementation of medicines access ... Val Gutteridge has also joined the team at Inceptua
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
